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The role of interleukin 8 (IL-8) in Plasmodium falcipa- 
rum malaria is unknown, although activation of the cyto- 
kine network and secretion of pro-inflammatory cyto- 
kines such as tumour necroiis factor (TNF) &d 
interleukin 6 (IL-6) does occur. IL-8 is secreted bv manv 
cells including monocytes, macrophages and end&heli& 
cells. It is a chemoattractant and activator of neutrophils 
and is also chemotactic for T cells (BAGGIOLINI et al., 
1989). However, there are few in v&o data on IL-8 in 
clinical infections. We have investigated plasma IL-8 
concentrations in a pilot study of 6 patients with rela- 
tively severe? but non-fatal, non-cerebral, I’. falciparum 
malaria admltted consecutively to the Hospital for Tropi- 
cal Diseases, Bangkok, Thailand. The study was ap- 
proved by the ethics committee of the Faculty of Tropi- 
cal Medicine, Mahidol University, Thailand. 
Following diagnosis of malaria by microscopical exam- 
ination of thick and thin blood films. 5 ml blood samules 
were taken immediatelv before initiation of treatGent 
(artemether or artesunate and appropriate supportive 
therapy), then daily for 7 d and weekly thereafter until 
discharge at 1 month. The prolonged admission policy at 
the Hosuital for Tronical Diseases ensures that there is 
no secoid episode of-infection in patients and allows in- 
sight into the natural history of a single treated episode of 
malaria. Samples were collected into endotoxin-free 
tubes containing the anticoagulant potassium ethylene 
diaminetetraacekte and 100 cl1 trasylol, a protease in- 
hibitor. Thev were then centrifuged (1000 a for 5 min at 
4°C) and plasma was stored at -70°6for a maximum of 2 
months. IL-8 was measured with a previously described 
enzyme-linked immunosorbent assay (ELISA) (DEFORGE 
& REMICK, 1991). Plasma TNF and IL-6 concentrations 
were measured usinn established bioassavs (ESPEVIK & 
NISSEN-MEYER, 198%; AARDEN et al., 1987): The lower 
limit of sensitivitv of the TNF assav was 23 De/ml. of the 
IL-6 assay 1 pgjml, and of the iL-8 EL&A-95 ‘pg/ml. 
Standard curves were determined for all assays, which 
were performed with appropriate control samples and 
carried out in a ‘blinded’ fashion by a laboratory unaware 
of the clinical details. 
The 6 patients were all male, aged between 16 and 45 
years; their initial peripheral parasitaemias were 2.1%, 
5.6%, 7.0%, 7.6%, 7.8% and 13%. None had evidence of 
cerebral malaria and all recovered following treatment. 
Five patients had abnormal liver function tests with 
raised serum bilirubin and transaminases. One patient 
required haemodialysis and cytokine analyses were dis- 
continued as renal replacement therapy may activate the 
cybokine network. A neutrophil le&ocyiosis (11.9~ 
10 /L, 84% neutronhils) was documented in only one pa- 
tient. ‘Malarial parasites’were cleared from the ci&latIon 
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within 3 d of starting specific treatment and all patients 
were afebrile within one week. 
The initial mean nlasma IL-8 concentration was raised 
at 216k9.5 pg/ml, bhich is similar to levels we have pre- 
viously recorded in patients with fatal Gram-negative 
sepsis (97-362 pgiml.). In normal healthy subjects with- 
out malaria no plasma IL-8 is detectable using this ELISA 
(DEFORGE & REMICK, 1991), and in control experiments 
we have found that the freezing and storage protocol 
used in this study does not affect plasma measurements. 
The prognostic significance of raised plasma IL-8 con- 
centration cannot be deduced from this small pilot study. 
IL-8 may be the stimulus for the leucocytosis found in 
some patients with severe malaria, although a raised neu- 
trophil count was found in only one patient in our study. 
The current data suggest that IL-8 has as yet uncharac- 
terized functions in host defence to this protozoa1 pa- 
thogen, unrelated to activation of neutrophils. Mononu- 
clear cells express the IL-8 gene folldwing adhesion 
(KASAHARA et al., 1991), suggesting a relationship be- 
tween IL-8 and the regulation of adhesion molecules, 
such as ICAM- 1. Such an interaction may be important if 
endothelial expression of intercellular adhesion-molecule 
1 (ICAM-1). an adhesion recentor for P. falcibarum in 
vitro (BERE~DT et al., 1989), is involved in capillary se- 
questration of the parasite with consequent organ dys- 
function in vivo. 
Admission plasma IL-6 concentrations detected by 
bioassay in these patients were slightly elevated at 
44k21.6 pgiml. This is similar to levels we have de- 
tected in relatively trivial bacterial infections but lower 
than the concentrations measured in African children 
with cerebral malaria (MOLYNEUX et al., 1991). This dif- 
ference may be important, as high plasma IL-6 concen- 
trations have been associated with poor prognosis in the 
African study and with organ damage in severe malaria 
in non-immune European adults (KERN et al., 1989). 
However, this discrepancy might reflect the fact that we 
have used a biological rather than an immunoradiometric 
assay. Bioactive TNF was detectable in the plasma of 4 
oatients on admission to the studv (12Ok65 &ml), at 
concentrations similar to those - previously- ;ep&ted 
(GRAU et al., 1989). 
An unexpected and interesting finding of the current 
study was that plasma IL-8 and IL-6 levels remained 
elevated throughout the period of investigation (Figure). 
Patients were studied for at least 3 weeks after they had 
become afebrile and recovered clinically from their ill- 
ness. In only one patient was plasma TNF bioactivity de- 
tected beyond day 7, the period during which fever set- 
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Pneumocystis carinii pneumonia and 
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infected with HIV 
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Although Pneumocystis car&ii is clearly recognized in 
North America and Europe as a leading cause of fatal 
pneumonia in malnourished children and immunocom- 
promised patients such as those with’the acquired immu- 
nodeficiency syndrome (AIDS) (BARTLETT & SMITH, 
19911, overt Dneumocvstosis has rarelv been recognized 
in AibS patients living in African Countries (INCAS, 
1988; FLEMING, 19901. On the contrarv. tuberculosis an- 
pears to be prevalent among African p&ulations infect&d 
with human immunodeficiency virus (HIV) (LUCAS, 
1988; FLEMING, 1990). 
Eighty-three adult patients (38 male, 45 female, mean 
age 25.3 years, range 18-38 years) infected with HIV and 
with respiratory symptoms, dwelling in Malenga Makali 
rural area, Iringa district, Tanzania, were studied to 
determine the prevalence of P. carinii infection and 
tuberculosis during 5 months ending 29 December 1991. 
Patients were enrolled if they were HIV seropositive and 
presented with dyspnoea, cough, fever of at least two 
weeks duration, or overt pneumonia. HIV infection was 
assessed by positive serological results in 2 different com- 
mercially available tests, using freshly collected sera 
(HIV Check l-2@, DuPont, Wilmington, Delaware, 
USA and Recombinant ELISA@, Abbott, North Chicaao. 
Illinois, USA) and positive resklts confirmed by a co& 
mercial Western blot usina sera stored at -20°C IBio- 
tech@, DuPont). Sputum was collected after inhalatibn of 
hypertonic solution (NaCl 10%) from an ultrasonic 
nebulizer (Fisoneb@, Fisons, Rochester. New York. 
USA) for iO-15 min. About’1 ml of eadh sample was 
treated with a solution of dithiothreitol (SDutasoP. 
Oxoid, Basingstoke, Hampshire, England) fo; 15 min 
and centrifuged: the supernatant was discarded and 
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smears were prepared from the pellet. Slides were 
stained with toluidine blue 0 and Diff-Quik@ (Baxter, 
Switzerland). To detect mycobacteria, smears were 
stained with Ziehl-Neelsen to identify acid-alcohol resis- 
tant bacilli after 3-step decontamination using L-cysteine, 
benzalkonium chloride and albumin (Biomerieux, Italy) 
followed by centrifugation. Using a sterile wire loop, 
samples of the pellet were inoculated into tubes contain- 
ing Lowenstein- Jensen medium (Biomerieux) and incu- 
bated at 37°C. 
Three of 83 induced sputum specimens (3.6%) were 
positive for P. co&ii, in both Diff-Quik and toluidine 
blue 0 stained smears. The infection was confirmed by 
Giemsa staining. In addition, P. car&ii cvsts were obs- 
erved in 2 other smears stained with toluidine blue 0, 
bur these could not be confirmed bv Giemsa staining 
either because only empty cysts were bresent or because 
the infection was very scanty (both -preparations were 
heavily contaminated with fungi). Mycobacteria were 
found in 32183 (38.5%) preparations, and 11 cultures 
(13.2%) were positive; 21 other cultures were contami- 
nated. The isolates were all Mvcobacterium tuberculosis. 
fully sensitive to standard drugs. Two of the 3 patients 
infected with P. carinii also had concomitant pulmonary 
tuberculosis, as reported by MCLEOD et al. (1990) in 
Zimbabwe, and one of them died during therapy. 
As expected, M. tuberculosis appears to be a dominant 
pathogen in Tanzanian HIV-infected patients, by virtue 
of its high prevalence and pathogenicity also in immuno- 
competent subjects in the same area (personal observa- 
tions). Our study confirmed that tuberculosis among 
AIDS pat-ients often results in the sputum being very rich 
m mycobacteria. As emphasized in many studies in sev- 
eral African countries, tuberculosis remains one of the 
most common severe diseases associated with HIV infec- 
tion, probably because of its occurrence among popula- 
tions with low socioeconomic indices, gross exposure to 
the pathogen without previous vaccination, and failure of 
tuberculosis control measures (LUCAS, 1988; CHAULET, 
1990; MCLEOD et al., 1990). 
Even if P. cat% pneumonia seems to be of minor im- 
portance in tropical countries, our results confirmed that 
it occurs there, even if less frequently than in Europe and 
the USA (GRIFFIN & LUCAS, 1982; AIOYE, 1987; LUCAS, 
1988, 1990; LUCAS et al., 1989; ELVIN et al., 1989; 
MCLEOD et al., 1989; CARME et al., 1991; FLEMING 
1990; M’BOUSSA et al., 1991). As it has been also sero- 
logically demonstrated that P. carinii is present in 
healthy Gambian children (WAKEFIELD et al., 1990), it is 
probable that the parasite does not appear to be an im- 
